Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.

Episode metadata supplied by the publisher feed · Published Apr 30, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

0:00 4:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 4 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on April 30, 2025.

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!